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A B S T R A C T
Purpose: ILAE guidelines recommend the use of prolonged EEG where the diagnosis of epilepsy or the
classiﬁcation of the seizure syndrome is proving difﬁcult. Due to its limited provision, video EEG
monitoring is unavailable to many patients under investigation1. The aim of this study was to examine
the utility of the alternate investigation of outpatient ambulatory EEG.
Methods: In this retrospective study we analysed 324 consecutive prolonged outpatient ambulatory
EEGs lasting 72–96 h (4–5 days), without medication withdrawal. EEG data and the clinical record were
reviewed to investigate the utility of the investigation.
Results: Of 324 studies: 219 (68%) studies gave positive data, 116 (36%) showed interictal epileptiform
discharges (IEDs), 167 (52%) had events. 105 (32%) studies were normal. Overall 51% of studies changed
management of which 22% of studies changed the diagnosis and 29% of studies reﬁned the diagnosis by
classifying the epilepsy into focal or generalised.
Conclusion: The present study conﬁrms the diagnostic utility of outpatient ambulatory EEG in the
diagnosis of paroxysmal events.
Crown Copyright  2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Many authors have discussed the importance of correct
diagnosis and electro-clinical classiﬁcation in epilepsy in order
to prognosticate and utilise antiepileptic medication appropriate-
ly. A clinical diagnosis of epilepsy is found to be incorrect in up to
30% of patients.2,3 The common differential diagnoses of syncope
and psychogenic non epileptic attacks (PNEA) are notoriously hard
to diagnose, even the witnessed semiology can be misleading.4,5
A single 20-min duration routine EEG shows abnormalities in as
few as 30–50% of patients with epilepsy. Repeated 20 min studies
can increase the yield to 60–70%.6,7 A sleep EEG after an initial
negative routine EEG has been shown by several groups to reveal
IEDs in an additional 24–34% of patients.8 Most studies have
concluded that 10% of patients with epilepsy will not show IEDs
despite repeated testing with repeated EEG modalities.9 Before
conﬁrmation of diagnosis or correct classiﬁcation the patient may
be on inappropriate medication. There may also be a psychological
and ﬁnancial cost of an incorrect diagnosis in emergency* Corresponding author. Permanent address: Department of Neurology, North
Bristol NHS Trust, Frenchay Hospital, Bristol BS16 1LE, UK. Tel.: +44 1173403953;
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from work.
The ILAE recommends long term EEG monitoring where there is
diagnostic uncertainty as to the diagnosis of epilepsy, in conﬁrmed
epilepsy in order to classify the epilepsy syndrome, quantify
seizures or diurnal and circadian patterns, and to document the
electro-clinical basis of seizures prior to epilepsy surgery.1 The
majority of the literature on long term monitoring concentrates on
inpatient video EEG monitoring in epilepsy surgery cohorts with
severe epilepsy in whom drug withdrawal is carried out. Due to its
limited provision, video EEG monitoring is unavailable to many
patients under investigation.
The alternate investigation of prolonged outpatient ambulatory
EEG is a relatively recent inception as the technology to allow for
portable devices only became commercially available in 1979.
Outpatient ambulatory EEG does not allow direct observation of
the semiology of an event, nor does it provide a safe environment
for drug reduction. Where these factors are not relevant, enabling
patients to be investigated at home with exposure to their typical
seizure provoking factors, make outpatient ambulatory EEG an
attractive option.
Initial reports on 4 and 8 channel montages conﬁrmed the
reliability and utility of the modality.10–13 More recently studies
have reviewed the utility of computer assisted ambulatory EEG
with 1–2 days of monitoring.14,15 There have been no studies on
modern ambulatory EEG units with 32-channel capability for. Published by Elsevier Ltd. All rights reserved.
Fig. 1. The latency to recording events (in the 167 of 324 patients who had events).
Data expressed as percentages of patients who had any event (black line), seizures
(blue line) or non epileptic attacks (red line) against time in hours from onset of
recording.
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channels for reference, ground and ECG for prolonged periods at
sampling rates and quality comparable to inpatient video EEG
recordings. In this study we aim to characterise the utility of
outpatient ambulatory EEG in the investigation of paroxysmal
events.
2. Methods
In this retrospective study we analysed 324 consecutive
patients who underwent outpatient ambulatory EEGs, lasting
72–96 h, performed between 2007 and 2010, at the Royal Prince
Alfred Hospital in Sydney Australia where clinical follow up data
(from subsequent outpatient review) was available.
EEG and ECG data was acquired using the ProFusion ambulatory
digital 32-channel EEG system (Abbotsford, Australia) using the
standard 10–20-electrode placement. The system has a patient
activated event button. All patients were recorded as outpatients.
Each patient was recorded once for between 72 and 96 h. Patients
kept a diary of clinical events and witness accounts and returned
once every 24 h for electrode care, data download and battery
change. No home video was recorded. No patients underwent drug
tapering or withdrawal. The EEG was analysed independently
page-by-page by 2 EEG trained neurologists for the presence of
interictal EEG abnormalities and for EEG changes during events.
The epileptiform discharges and epileptic seizures were classiﬁed
as focal with or without secondary generalisation or generalised as
typical for symptomatic generalised epilepsy or primary general-
ised epilepsy.16 The patients’ clinical record was analysed for pre
test diagnosis, indication for test (diagnosis, classiﬁcation and
seizure frequency), post-test diagnosis and change of manage-
ment, age, sex, and age at ﬁrst seizure, seizure frequency,
antiepileptic drug use and MRI results.
Epilepsy duration (years) and latency to IED (minutes) were
log-transformed to remove skewness, thus achieving approximate
normality of these analyses. Determinants of ‘‘recording an event’’,
‘‘new information’’ and ‘‘seizure’’ were estimated using univariate
and multivariate logistic regression models. Determinants of
‘‘latency to events’’ were ascertained by an analysis of covariance
(ANCOVA). All of the data were analysed with SAS version 9.2 (SAS
Institute).
3. Results
We reviewed 324 consecutive patients undergoing 5-day
ambulatory EEG between 2007 and 2010 where clinical follow
up data was available. There were 192 (60%) females, 132 (40%)
males with a mean age of 39 years (range 12–79). 195 were on
antiepileptic drugs and 129 were not. 81 had abnormal MRI scans
(including hippocampal sclerosis, gliosis following head injury or
brain resections), 210 had normal MRI scans and in 33 the results of
MRI were not available. The mean duration of symptoms (since the
ﬁrst event) at time of monitoring was 12 years (range 1–64 years,
mode 1 year). The frequency of events reported by patients showed
a mean of 10 per month. The indication for the ambulatory EEG was
diagnostic in 193 (60%), classiﬁcation of epilepsy in 96 (30%) and to
conﬁrm the frequency of subclinical seizures in 35 (10%). The
provisional diagnosis was epilepsy in 210 (65%), a non-epileptic
diagnosis in 109(35%).
EEG results: Of the 324 studies, 219 (68%) of EEG studies gave
positive data (EEG abnormalities and/or events). 105 (32%) of EEG
studies were normal (neither EEG abnormalities nor events). Of the
324 studies: 122 (38%) showed evidence for epilepsy, 116 (36%)
showed IEDs, 52 (16%) had IEDs but no epileptic seizures, 6 (1.9%)
had epileptic seizures but no IEDs and 64 (20%) had IEDs and
typical events. Of the 64 studies with IEDs and typical events, 45(70%) showed epileptic seizures and IED, 15 (23%) showed both
PNEA and IEDs and 4 (7%) showed both PNEA and epileptic seizures
and IEDs.
167 (52%) had typical events. On the basis of witness accounts
and EEG interpretation of the 167 studies with events, 51 (31%)
were epileptic seizures, 96 (57%) were PNEA, 4 (2%) had both PNEA
and epileptic seizures and 16 (10%) were syncope.
We reviewed the latency to events observed within 96 h of
recording (Fig. 1). For any event, irrespective of diagnosis, 58% were
seen within 24 h, 78% within 48 h, 87% by 72 h and 100% by 96 h.
Latency to recording epileptic seizures was 51% within 24 h, 70%
within 48 h, 79% by 72 h and 100% by 96 h. Latency to recording
PNEA was shorter: 60% within 24 h, 82% within 48 h, 92% by 72 h
and 100% by 96 h although this did not reach statistical
signiﬁcance (ANCOVA).
Clinical effect of EEG results: Of the 324 studies, 146 (45%)
conﬁrmed the pre test diagnosis of epilepsy, syncope or
psychogenic non epileptic attacks. 93 (29%) studies reﬁned the
diagnosis (by classifying the epilepsy as focal or generalised) and
85 (26%) studies changed the diagnosis. 16 (5%) diagnoses were
changed from epilepsy to syncope, 51 (16%) diagnoses changed
from epilepsy to psychogenic non epileptic attacks, 10 (3%)
diagnoses were changed from PNEA to epilepsy and 4 (1%) patients
had diagnoses changed from epilepsy to epilepsy and PNEA.
Determinants of EEG results and clinical outcomes: Determinants
of recording an event vs. no event were analysed (Table 1).
Multivariate analysis showed that a higher frequency of reported
events and a test indication of classiﬁcation of the epilepsy were
the only signiﬁcant determinants of recording an event during the
study. No other factors were independent determinants.
Determinants of recording an epileptic seizure vs. PNEA
(excluding other diagnoses such as syncope) were analysed (Table
2). Multivariate analysis found no pre-test patient factors could
differentiate between the likelihood of recording epileptic seizures
vs. PNEA. The indication for the test was the only signiﬁcant
determinant of recording epileptic seizure vs. non-epileptic event.
Epileptic seizure was more likely if the indication was to classify
epilepsy or to conﬁrm the frequency of events. PNEA was more
likely if the test indication was diagnostic.
Determinants of latency to recording an event (in days) were
analysed. There were no pre-test factors that were signiﬁcant
determinants of latency. Multivariate analysis showed generalised
epilepsy to have a shorter latency to seizures during monitoring.
Whilst this was statistically signiﬁcant the number of cases was
Table 1
Determinants of recording an event vs. no event were analysed using univariate and multivariate logistic regression models.
Crude Multivariate-adjusted
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Age (years)* 0.88 (0.71–1.08) 0.23 0.97 (0.67–1.41) 0.88
Sex (female vs. male) 1.28 (0.84–1.95) 0.26 1.00 (0.51–1.95) 0.99
Log of epilepsy duration (years)* 1.25 (0.97–1.61) 0.09 1.14 (0.80–1.63) 0.48
Reported frequency (vs. 0 per 28 days)
0.4 per 28 days 3.96 (0.74–21.28) 0.11 0.58 (0.23–1.46) 0.25
1 per 28 days 8.44 (1.85–38.44) 0.006 0.99 (0.50–1.96) 0.99
4 per 28 days 14.24 (3.20–63.28) 0.001 1.15 (0.60–2.18) 0.68
10 per 28 days 24.73 (4.25–143.98) 0.0004 1.84 (0.55–6.17) 0.33
28 per 28 days 60.75 (13.36–276.17) <0.0001 5.04 (2.56–9.92) <0.0001
Lesion on MRI (yes vs. no) 1.81 (1.09–2.99) 0.02 1.68 (0.82–3.44) 0.15
Antiepileptic drug (yes vs. no) 1.16 (0.76–1.79) 0.49 1.12 (0.49–2.54) 0.79
Provisional diagnosis (vs. non-epilepsy)
Epilepsy 0.88 (0.56–1.38) 0.57 1.58 (0.61–4.05) 0.34
Both epilepsy and non-epilepsy 4.30 (0.87–21.18) 0.07 4.26 (0.42–43.59) 0.22
Indication (vs. diagnosis)
Classiﬁcation 0.46 (0.28–0.73) 0.001 0.26 (0.10–0.63) 0.003
Frequency 1.47 (0.71–3.03) 0.30 1.79 (0.51–6.22) 0.36
* odds ratio for continuous variables represent a difference of a SD (15.6 years for age and 1.26 for log-transformed epilepsy duration).
Table 2
Determinants of recording a seizure event vs. a non epileptic attack were analysed using univariate and multivariate logistic regression models.
Crude Multivariate-adjusted
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Age (years)* 1.13 (0.78–1.64) 0.51 0.48 (0.22–1.04) 0.06
Sex (female vs. male) 0.61 (0.30–1.22) 0.16 1.00 (0.28–3.55) 0.99
Log of epilepsy duration (years)* 1.62 (1.02–2.59) 0.04 0.92 (0.41–2.02) 0.83
Reported frequency (vs. 0 or 0.4 per 28 days)**
1 per 28 days 4.33 (0.61–30.57) 0.14 0.16 (0.01–2.34) 0.18
4 per 28 days 0.87 (0.14–5.55) 0.88 0.35 (0.03–4.15) 0.40
10 per 28 days 1.00 (0.11–8.95) 0.99 0.29 (0.01–6.54) 0.44
28 per 28 days 0.65 (0.11–3.92) 0.64 0.99 (0.10–9.98) 0.99
Lesion on MRI (yes vs. no) 2.89 (1.36–6.13) 0.006 0.53 (0.15–1.88) 0.33
Antiepileptic drug (yes vs. no) 2.69 (1.20–6.00) 0.02 1.54 (0.32–7.33) 0.59
Provisional diagnosis (vs. non-epilepsy)
Epilepsy 8.84 (2.93–26.65) 0.0001 0.84 (0.13–5.32) 0.85
Both epilepsy and non-epilepsy 5.12 (0.70–37.26) 0.11 0.76 (0.06–9.10) 0.83
Indication (vs. diagnosis)
Classiﬁcation 10.15 (4.20–24.55) <.0001 0.13 (0.02–0.70) 0.02
Frequency 11.92 (3.88–36.61) <.0001 0.07 (0.01–0.49) 0.008
Number of events recorded > median(3) 1.45 (0.72–2.90) 0.30 0.52 (0.13–2.11) 0.36
Latency to event (days)* 1.41 (1.01–1.97) 0.04 0.81 (0.41–1.61) 0.54
* odds ratio for continuous variables represent a difference of a SD (15.6 years for age, 1.26 for log-transformed epilepsy duration and 1.05 for latency to event).
** 0 and 0.4 were combined because event number was 0.
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recorded was a determinant of the latency to the ﬁrst event.
Financial costs of outpatient ambulatory EEG vs. inpatient video
EEG: In our unit we have compared the cost of outpatient aEEG
with inpatient vEEG. In order to determine this we calculated the
costs for staff wages, clinic or inpatient space, consumables and
equipment depreciation. In our unit, inpatient video EEG costs
$948 (AUS) for each 24-h period. Outpatient ambulatory EEG costs
$237 (AUS) for each 24-h period. In our department, inpatient
videoEEG therefore costs 4 times as much to perform.
4. Discussion
We evaluated the utility of ambulatory EEG in the investigation
of paroxysmal events. The present study shows that ambulatory
EEG changed or reﬁned the diagnosis in 51% of patients. Of those
events recorded during a 96 h EEG, 58% were recorded within 24 h
and 78% within 48 h.Two previous studies have been performed on the utility of
ambulatory EEG recorded for 1–2 days. Most recently a study on
computer assisted ambulatory EEG in 502 patients showed 47%
with events of which 13% were epileptic seizures and 87% non-
epileptic.15 Morris et al.14 reviewed 344 patients with computer
assisted EEG, recorded for a median duration of 1.4 days. Their
study showed a 48% event rate: 20% of which were epileptic
seizures and 80% non-epileptic. Overall their study reported a
clinical usefulness of 75%. Our study shows similar rates of event
detection although our ratio of epileptic seizures to non-epileptic
events was much higher at 30%. This may reﬂect patient selection
criteria, but also may reﬂect the advances in ambulatory EEG
technology allowing for 32 channels over the previous 16 channels
and thus a full standard 10–20 montage. Both the above studies
recorded EEG for shorter periods than our study. As psychogenic
non-epileptic attacks are overrepresented in the ﬁrst 24 h this may
also be a factor. From our data, 42% and 22% of ﬁrst events would
have been missed if the recording were for 24 or 48 h respectively.
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diagnostic utility of video EEG although there has been no
randomised comparison with ambulatory EEG. One study has
looked at assessments with both video and ambulatory EEG carried
out during an inpatient admission with drug withdrawal (patients
may have had video EEG, ambulatory EEG or both) but the patients
were not randomised.17 Of 364 ﬁrst EEG assessments, they
described a change or reﬁnement of diagnosis in 133 (37%)
although many of their admissions were pre-surgical or for
medication changes. Of those referred for diagnostic clariﬁcation,
71% had a change or reﬁnement of the diagnosis. They calculated
the duration of EEG required to change management as 78 h of
ambulatory EEG and 60 h of video EEG. In another study of 131
patients where inpatient video EEG was recorded for a mean period
of 5.6 days, events were recorded in 69%, and 43% showed interictal
discharges.18 In this video EEG study the diagnosis was altered or
reﬁned in 58% of patients, similar to the 51% in our study.
In our study, none of the pre test clinical variables were shown
to be determinants of the type of event recorded. As would be
expected, psychogenic non epileptic attacks were more likely if the
test indication was diagnostic and epileptic seizures were more
likely if the referring clinician requested the investigation for
electroclinical classiﬁcation of epilepsy. Many previous studies
have failed to show patient factors that predict psychogenic non
epileptic attacks over epileptic seizures.19 Whilst there is an
association with previous psychological life events this is not a
reliable determinant and one must remember that both epilepsy
and PNEA may coexist. For the present time we will have to rely on
the outcome of EEG investigations to differentiate between these
diagnoses.
Pre test clinical variables including the presence or absence of
antiepileptic drugs and MRI results did not predict which patients
would have a short latency to recording events (p < 0.05 ANCOVA).
The patients’ reported frequency of events has been studied in both
ambulatory and video EEG as a determinant of latency to events
during monitoring. As in the present study, this has been shown to
be a very poor predictor of latency to events during monitoring.20
Whilst there was a trend towards shorter latency to psycho-
genic non epileptic attacks, overall there was no statistically
signiﬁcant difference between the latency to events irrespective of
the diagnosis. This is in contrast to other inpatient studies on
psychogenic non epileptic attacks, which suggest a shorter latency
to ﬁrst event.21 This difference may be due to the reported
suggestibility of events in clinical situations such as a video-
monitoring unit.22 Multivariate analysis showed generalised
epilepsy to have a shorter latency to seizures during monitoring.
There were a small number of cases of generalised epilepsy and
this group included some cases of symptomatic generalised
epilepsy where frequent seizures were recorded which will skew
the data. Overall 58% of events were seen within 24 h, 78% within
48 h, 87% by 72 h and 100% by 96 h. Therefore 22% of events were
seen in the second half of a 96 h recording. This is in contrast to the
latency to interictal epileptiform abnormalities. In this situation
95% of IEDs seen in a 96 h EEG will be seen in the ﬁrst 48 h.23
There are limitations to our data set: we do not have data on the
delay from the last seizure to EEG monitoring and although most
patients will have undergone a 20-min routine EEG prior to referral
to the epilepsy clinic we do not have this data. Both these factors
may change the likelihood of detecting an event or an IED in
epileptic patients. Furthermore, we are unable to conﬁrm the
increase in pick up of IEDs during a prolonged ambulatory EEG over
a routine 20-min EEG. We have included a diverse group of patients
in the study to reﬂect the range of patients investigated in a
specialist epilepsy clinic.
The DMC Neurophysiology Subcommittee of the ILAE recom-
mend the use of hospital based long term monitoring where thediagnosis of epilepsy or the classiﬁcation of the seizure syndrome
is proving difﬁcult.1 This guidance also states that ‘‘ambulatory
outpatient and community-based LTM may be used as a substitute
for inpatient LTM in cases where the latter is not cost-effective or
feasible or when activation procedures aimed at increasing seizure
yield are not indicated.’’
There are innate limitations to outpatient ambulatory EEG
recordings. The technique relies upon diary data and witness
accounts of events to help interpret the EEG rather than objective
video data. There may be occasions when the history and witness
account suggest psychogenic non epileptic attacks and the EEG
seizure is obscured by motor artefacts. Furthermore artefacts may
be confused with IEDs or epileptic seizures by the less experienced
observer. In these instances the correlation of video with EEG is
essential. The use of home video recording to supplement
outpatient ambulatory EEG has not been studied but may
overcome some of these limitations. In general ambulatory EEG
has been poorly studied given its widespread use in clinical
practice. For example there are no studies directly comparing
inpatient videoEEG with outpatient ambulatory EEG and this
represents an important future research direction.
5. Conclusion
Whilst video EEG will remain the gold standard for conﬁrming
the electrophysiology underlying a given event, this may be
unnecessary for the initial diagnosis of paroxysmal events. The
present study conﬁrms the diagnostic utility of outpatient
ambulatory EEG in the investigation of paroxysmal events. Given
the limited provision and higher cost of inpatient video EEG,
outpatient ambulatory EEG represents a practical initial investi-
gation in the investigation of paroxysmal neurological events.
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